65 related articles for article (PubMed ID: 11726924)
1. Absence of ST7 mutations in tumor-derived cell lines and tumors.
Hughes KA; Hurlstone AF; Tobias ES; McFarlane R; Black DM
Nat Genet; 2001 Dec; 29(4):380-1. PubMed ID: 11726924
[TBL] [Abstract][Full Text] [Related]
2. Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31.
Zenklusen JC; Conti CJ; Green ED
Nat Genet; 2001 Apr; 27(4):392-8. PubMed ID: 11279520
[TBL] [Abstract][Full Text] [Related]
3. Absence of ST7 gene alterations in human cancer.
Dong SM; Sidransky D
Clin Cancer Res; 2002 Sep; 8(9):2939-41. PubMed ID: 12231539
[TBL] [Abstract][Full Text] [Related]
4. Mutation of the ST7 tumor suppressor gene on 7q31.1 is rare in breast, ovarian and colorectal cancers.
Thomas NA; Choong DY; Jokubaitis VJ; Neville PJ; Campbell IG
Nat Genet; 2001 Dec; 29(4):379-80. PubMed ID: 11726923
[TBL] [Abstract][Full Text] [Related]
5. Lack of mutations within ST7 gene in tumour-derived cell lines and primary epithelial tumours.
Brown VL; Proby CM; Barnes DM; Kelsell DP
Br J Cancer; 2002 Jul; 87(2):208-11. PubMed ID: 12107844
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the ST7 gene in human myeloid tumor cell lines.
Sivasundaram K; Suzuki H; Seto M; Hosokawa Y
Oncol Rep; 2003; 10(6):1737-9. PubMed ID: 14534688
[TBL] [Abstract][Full Text] [Related]
7. An LOH and mutational investigation of the ST7 gene locus in human esophageal carcinoma.
Wang S; Mori Y; Sato F; Yin J; Xu Y; Zou TT; Olaru A; Kimos MC; Perry K; Selaru FM; Deacu E; Sun M; Shi YC; Shibata D; Abraham JM; Greenwald BD; Meltzer SJ
Oncogene; 2003 Jan; 22(3):467-70. PubMed ID: 12545169
[TBL] [Abstract][Full Text] [Related]
8. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
[TBL] [Abstract][Full Text] [Related]
9. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.
Kittiniyom K; Mastronardi M; Roemer M; Wells WA; Greenberg ER; Titus-Ernstoff L; Newsham IF
Genes Chromosomes Cancer; 2004 Jul; 40(3):190-203. PubMed ID: 15138999
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and characterization of ST7R (ST7-like, ST7L) on human chromosome 1p13, a novel gene homologous to tumor suppressor gene ST7 on human chromosome 7q31.
Katoh M
Int J Oncol; 2002 Jun; 20(6):1247-53. PubMed ID: 12012006
[TBL] [Abstract][Full Text] [Related]
11. Frequent polymorphic changes but rare tumor specific mutations of the LATS2 gene on 13q11-12 in esophageal squamous cell carcinoma.
Ishizaki K; Fujimoto J; Kumimoto H; Nishimoto Y; Shimada Y; Shinoda M; Yamamoto T
Int J Oncol; 2002 Nov; 21(5):1053-7. PubMed ID: 12370754
[TBL] [Abstract][Full Text] [Related]
12. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.
Knowles MA; Habuchi T; Kennedy W; Cuthbert-Heavens D
Cancer Res; 2003 Nov; 63(22):7652-6. PubMed ID: 14633685
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer.
Liu MC; Choong DY; Hooi CS; Williams LH; Campbell IG
Cancer Lett; 2007 Mar; 247(1):91-7. PubMed ID: 16644110
[TBL] [Abstract][Full Text] [Related]
14. Functional evidence from microcell-mediated chromosome transfer of myeloid leukemia suppressor genes on human chromosomes 7 and 11.
Wilding J; Meijne E; Haines J; Moody J; Edwards A; Newbold RF; Parris C; Cox R; Silver A
Genes Chromosomes Cancer; 2002 Aug; 34(4):390-7. PubMed ID: 12112528
[TBL] [Abstract][Full Text] [Related]
15. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
16. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
[TBL] [Abstract][Full Text] [Related]
17. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
[TBL] [Abstract][Full Text] [Related]
20. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]